PROL1 Over-expressing Prostate Cancer Cell Line (LNCaP-PROL1+)
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Prostate |
| Organism |
Human (H. sapiens) |
| Donor History |
Male ,Caucasian ,50 ,Prostate carcinoma |
| Growth Properties |
Adherent ,Epithelial |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. RPMI 1640 Medium (TM503) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. 1.5 µg/ml Puromycin (G264) for selection. Note: Selection drugs should be added to the culture medium after the first passage to ensure cells have recovered from freeze-thaw conditions. |
| Immortalization Method | |
| Full Information |
PROL1 overexpresison has been associated with cancer, playing a role in overcoming the hypoxic barrier that develops as tumors grow. LNCaP cells were transduced with commercially available human PROL1 lentival particles according to manufacturer protcol and slected with 5 ug/ml puroycin. RNAseq and qt-RT- PCR was used to confirm overexpression of PROL1. There was >28,560-fold overexpression of PROL1 in LNCaP-ProL1+ relative to LNCaP (by qt-RT-PCR). Cells overexpressing PROL1 show greater cell motility and migration compared to parental cells.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
